RNA therapeutics
2022

Overview of RNA Therapeutics

Editorial

Author Information

Author(s): Tony Gutschner

Primary Institution: Martin Luther University Halle-Wittenberg

Conclusion

The articles presented highlight the potential and challenges of RNA therapeutics, emphasizing the need for further research to engineer and deliver patient-specific RNA-based drugs.

Supporting Evidence

  • RNA has many roles in cells, including acting as a messenger and engaging in various cellular processes.
  • mRNA vaccines have shown rapid development and efficacy in combating COVID-19.
  • Chemical modifications of RNA are critical to prevent toxicity and improve delivery.

Takeaway

RNA can do many important jobs in our cells, and scientists are trying to use it to make new medicines, but there are still some problems to solve.

Limitations

Development of RNA therapeutics is limited by inefficient delivery to specific tissues and the challenge of translating in vitro results to in vivo models.

Digital Object Identifier (DOI)

10.1080/15476286.2022.2161704

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication